Highlighted text has been updated as of November 13, 2024. The MATTERHORN trial showed that M-TEER is noninferior to surgical mitral valve repair regarding clinical efficacy and has a better safety ...

Degenerative mitral valve disease is common. Up to a quarter of patients with degenerative mitral valve disease may be asymptomatic despite having severe valve regurgitation. Current guideline ...

Association of Tricuspid Regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip system: 30‐day and 12‐month follow‐up from the GRASP ...

Background: Limited data exists describing Impella-related mechanical mitral valve complications. Diagnosis and management can be challenging due to potential underestimation of mitral regurgitation ...

Echo parameters: The beneficial effect of transcatheter mitral valve replacement compared with GDMT alone was consistent in all echocardiographic subgroups, independent of the severity of LV ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement ...

Mitral valve repair (MVRepair) has become the procedure of choice to correct severe degenerative mitral regurgitation (MR), due to its documented superiority to valve replacement regarding long-term ...

HealthDay News — For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields ...

LATE-breaking research presented at PCR London Valves 2024 has demonstrated the early safety and effectiveness of the transfemoral J-valve transcatheter heart valve (THV) system, achieving high ...